Governed clinical rules.
Published thresholds and population-specific criteria inform the clinical rules. Source references, review decisions and version history document their clinical basis and maintenance.
Everra Health / Clinical Foundation
A defined scope. An explicit methodology.
Clinical logic. Open to review.
Everra connects cardiometabolic findings through explicit clinical rules and synthesis methods, with the supporting basis available for clinician review.
Explore the review approach ↓Initial clinical scope
Six domains.
One cardiometabolic focus.
Everra’s initial scope covers cardiovascular, lipid, metabolic, inflammatory, autonomic and sleep findings. Its synthesis methodology defines when those findings can be connected.
Cardiovascular
Lipids
Metabolic
Inflammation
Autonomic
Sleep
Evidence and Everra methodology
The evidence. The synthesis method.
Governed interpretation.
Everra’s synthesis methodology specifies how related findings are resolved and connected across domains and time. These methods are documented separately from the evidence behind individual rules.
Traceability links an interpretation to its contributing data and logic. Auditability means being able to reconstruct the processing steps and versions used. Determinism means the same inputs and governed configuration produce the same result. None of these, alone, establishes clinical usefulness.
Inside the synthesis step
How findings become a connected picture.
The methodology addresses overlapping findings, pattern formation, change over time and cross-domain relationships. Each important synthesis decision should be explicit and open to review.
Resolution
Handle overlapping or competing findings.
Pattern formation
Establish when findings support a pattern.
Longitudinal interpretation
Interpret comparable observations over time.
Cross-domain synthesis
Connect findings only when justified.
Missingness and uncertainty
Separate normal findings from not enough information.
Three related questions
Our review approach.
Sources and review decisions.
Substantial clinical-rule review work includes sources, reviewer decisions, audits and version history. Closeout remains in progress.
How the findings fit together.
The proposed informatics review focuses on overlap, pattern formation, change over time, cross-domain links, missingness and uncertainty.
A separate methodology.
The meaning of a composite number, its combination and weighting, and validation for its intended use are separate from review of the individual rules.
These workstreams are not interchangeable. Repeatability and backward traceability are also technical implementation checks—not substitutes for clinical validation.
Status: 2 October 2026. Main six-domain clinical peer review is complete, and the scoring and synthesis architecture has completed independent physician-informatics review. Golden Case runtime verification and external clinical validation remain in progress; completed clinical validation is not claimed.
Development status
Where Everra is today.
Everra separates what has been built and reviewed from what still needs to be tested in clinical use.
BUILT
Six-domain MVP
Main clinical peer review across all six cardiometabolic MVP domains is complete. The deterministic interpretation pipeline is implemented and moving through final reconciliation, Golden Case verification, and production-freeze QA.
REVIEWED
Scoring & synthesis architecture
The synthesis architecture has completed an independent clinical informatics review. The assessment supported retaining the core deterministic architecture while recommending tighter governance around family resolution, score and completeness handling, synthesis, longitudinal comparability, and end-to-end verification.
STILL TO VALIDATE
Clinical usefulness
External clinical validation and real-world pilot performance remain to be established before broader clinical use.
Everra is currently pre-pilot. The core clinical interpretation pipeline does not rely on generative AI, and completed clinical validation is not claimed.
A considered evaluation
Bring your clinical questions.
Discuss coherence, justification, evaluation needs and priorities before a clinical pilot.